The ESMO Targeted Anticancer Therapies Virtual Congress 2021, known as “The Home of Phase I in Oncology” will offer participants a glimpse of the future of targeted anticancer therapies. It is the premier international meeting focusing on promising new anticancer targets and agents, with a particular focus on those in early phase clinical development. Stakeholders from academy and industry will discuss with clinicians, researchers and regulators the global dissemination of knowledge and clinical research expertise in the field of innovative cancer therapeutics, to the benefit of cancer patients worldwide.

1 March 2021 — 2 March 2021
2:40 pm

Online Zurich

Link to the conference